Cargando…
Target-based therapeutic matching of phase I trials in patients with metastatic breast cancer in a tertiary referral centre
BACKGROUND: Greater understanding of the molecular classification of breast cancer has permitted the development of rational drug design strategies. In a phase I clinical trial setting, molecular profiling with next-generation sequencing of individual tumour samples has been employed to guide treatm...
Autores principales: | O’Carrigan, Brent, Lim, Joline Si Jing, Jalil, Awais, Harris, Samuel John, Papadatos-Pastos, Dionysis, Banerji, Udai, Lopez, Juanita, de Bono, Johann Sebastian, Yap, Timothy Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203714/ https://www.ncbi.nlm.nih.gov/pubmed/30318518 http://dx.doi.org/10.1038/s41416-018-0290-8 |
Ejemplares similares
-
Targeting Brain Metastases in Patients with Melanoma
por: Papadatos-Pastos, Dionysis, et al.
Publicado: (2013) -
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors
por: Yap, Timothy A., et al.
Publicado: (2020) -
A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic
por: Tiu, Crescens, et al.
Publicado: (2020) -
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors
por: Papadatos-Pastos, Dionysis, et al.
Publicado: (2022) -
Combining targeted therapeutics in the era of precision medicine
por: Papadatos-Pastos, D, et al.
Publicado: (2015)